Pre-clinical study of amcenestrant and HER2-targeted therapies in HER2+/ER+ breast cancer cell line models

被引：1
|
作者：
Mahdi, Amira F.
Ashfield, Niall
Conlon, Neil T.
Crown, John
Collins, Denis M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-07-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-16
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Predicting benefit from HER2-targeted therapies in patients with ER+/HER2+breast cancer
    Turnbull, A. K.
    Webber, V.
    McStay, D.
    Arthur, L.
    Martinez-Perez, C.
    Fernando, A.
    Renshaw, L.
    Keys, J.
    Clarke, R.
    Sims, A. H.
    Dixon, J. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Targeted therapies for ER+/HER2-metastatic breast cancer
    Yamamoto-Ibusuki, Mutsuko
    Arnedos, Monica
    Andre, Fabrice
    BMC MEDICINE, 2015, 13
  • [3] Targeted therapies for ER+/HER2- metastatic breast cancer
    Mutsuko Yamamoto-Ibusuki
    Monica Arnedos
    Fabrice André
    BMC Medicine, 13
  • [4] Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes
    Wu Ding
    Dengfeng Ye
    Haifeng Chen
    Yingli Lin
    Zhian Li
    Chuanjian Tu
    Breast Cancer, 2024, 31 : 295 - 304
  • [5] HER2-Targeted Therapies in HER2-Low-Expressing Breast Cancer
    Dekker, Tim Johannes Adrianus
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28)
  • [6] ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2+ Breast Cancer
    Arciero, Cletus A.
    Guo, Yi
    Jiang, Renjian
    Behera, Madhusmita
    O'Regan, Ruth
    Peng, Limin
    Li, Xiaoxian
    CLINICAL BREAST CANCER, 2019, 19 (04) : 236 - 245
  • [7] HER2-targeted therapies beyond breast cancer - an update
    Yoon, Jeesun
    Oh, Do-Youn
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (09) : 675 - 700
  • [8] Cardiac Complications of HER2-Targeted Therapies in Breast Cancer
    Addetia K.
    DeCara J.M.
    Current Treatment Options in Cardiovascular Medicine, 2016, 18 (6)
  • [9] HER2-targeted therapies — a role beyond breast cancer
    Do-Youn Oh
    Yung-Jue Bang
    Nature Reviews Clinical Oncology, 2020, 17 : 33 - 48
  • [10] HER2-targeted therapies - a role beyond breast cancer
    Oh, Do-Youn
    Bang, Yung-Jue
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (01) : 33 - 48
12345